Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Inverness buys 76% of Standard Diagnostics for KRW242bn

Executive Summary

Inverness Medical Innovations has agreed to acquire 75.79% of public South Korean firm Standard Diagnostics for approximately KRW242bn ($215.6mm) in cash, or KRW40k per share.
Deal Industry
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
    • Glucose Testing
    • Urine-based Testing
  • Medical Devices
    • Monitoring Equipment & Devices
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register